Get the Stockscreener App
0.5001
1.92%
-0.0098
Pre-market:
.51
0.0099
+1.98%
Leap Therapeutics Inc Stock (LPTX) Latest News
Get in on Leap Therapeutics Inc’s (LPTX) buy-in window today! - SETE News
Leap Therapeutics Inc (LPTX) stock analysis: A simple moving average approach - US Post News
What is HC Wainwright's Estimate for LPTX FY2029 Earnings? - MarketBeat
Leap Therapeutics (NASDAQ:LPTX) Downgraded by Baird R W to "Hold" - MarketBeat
Leap Therapeutics (NASDAQ:LPTX) Downgraded to "Neutral" Rating by HC Wainwright - MarketBeat
Leap Therapeutics (NASDAQ:LPTX) Cut to "Neutral" at Robert W. Baird - MarketBeat
FY2029 Earnings Estimate for LPTX Issued By HC Wainwright - Defense World
Robert W. Baird Downgrades Leap Therapeutics (NASDAQ:LPTX) to Neutral - Defense World
Leap Therapeutics (NASDAQ:LPTX) Rating Lowered to “Neutral” at HC Wainwright - Defense World
Leap Therapeutics Reports Promising Initial Clinical Data, Updates Corporate Presentation - Defense World
Baird R W Downgrades Leap Therapeutics (NASDAQ:LPTX) to Hold - Defense World
Leap reports positive colorectal cancer study results - MSN
Leap Therapeutics stock rating cut by H.C. Wainwright to Neutral - MSN
Baird cuts Leap Therapeutics stock rating, slashes target - MSN
Leap Therapeutics stock hits 52-week low at $0.8 - MSN
Leap Therapeutics cut to Neutral at Baird after mid-stage trial setback - MSN
Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright -January 29, 2025 at 03:02 pm EST - Marketscreener.com
Leap Therapeutics stock cut to Neutral at Baird (LPTX:NASDAQ) - Seeking Alpha
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Baird Downgrades Leap Therapeutics to Neutral From Outperform, Cuts Price Target to $1.25 From $9 - Marketscreener.com
HC Wainwright Downgrades Leap Therapeutics to Neutral From Buy -January 29, 2025 at 07:17 am EST - Marketscreener.com
Leap halts gastric cancer program, changes course - The Pharma Letter
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline - MSN
Leap Therapeutics stock hits 52-week low at $0.8 By Investing.com - Investing.com Nigeria
Health Care Cos Down Amid Rotation into Tech -- Health Care Roundup -January 28, 2025 at 05:45 pm EST - Marketscreener.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Leap Therapeutics Shares Drop After Discontinuing Phase 3 Studies of Gastric Cancer Treatment - Marketscreener.com
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipe - Asianet Newsable
Leap Therapeutics stock plummets as it will discontinue DisTinGuish study in advanced gastric cancer - MSN
Why Is Leap Therapeutics Stock Trading Lower On Tuesday?Leap Therapeutics (NASDAQ:LPTX) - Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results - Benzinga
Leap Therapeutics: 2 Cancer Trials Disappoint, But There Is A Silver Lining (NASDAQ:LPTX) - Seeking Alpha
Stock market news: Vincerx Pharma plunged by 95.86% while MiNK Therapeutics was down by 94.26% during mid day trading - Business Upturn
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results - Benzinga
Stock market today: Vincerx Pharma declined by 95.75% whereas Revelation Biosciences - Business Upturn
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings - Benzinga
Leap reports positive colorectal cancer study results By Investing.com - Investing.com South Africa
Leap crashes as midphase data mark end of gastric cancer program - Fierce Biotech
Leap Therapeutics Shares Slide After Initial Mid-Stage Cancer-Drug Results - MarketWatch
Leap stock tumbles on mid-stage trial setback (LPTX:NASDAQ) - Seeking Alpha
Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study - Yahoo Finance
Delayed Dream Sleep Linked to Alzheimer's Risk - 69News WFMZ-TV
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):